K. Young

发表

Pre-Clinical Autoimmunity in Lupus Relatives: Self-Reported Questionnaires and Immune Dysregulation Distinguish Relatives Who Develop Incomplete or Classified Lupus From Clinically Unaffected Relatives and Unaffected, Unrelated Individuals

J. Norris, M. Weisman, D. Karp, 2022, Frontiers in Immunology.

Relationship Between a Vitamin D Genetic Risk Score and Autoantibodies Among First-Degree Relatives of Probands With Rheumatoid Arthritis and Systemic Lupus Erythematosus

P. Gaffney, J. Norris, C. Langefeld, 2022, Frontiers in Immunology.

Lupus Erythematosus: A Potential Role in Systemic a for IFN-Receptor Type 2 (CR2/CD21) as a Receptor Characterization of Human Complement

V. Holers, J. Hannan, R. Asokan, 2006 .

Novel inhibitory monoclonal antibodies to human CR2/CD21 ligand binding domains

J. Lambris, S. Perkins, J. Guthridge, 2000 .

Characterization of Human Complement Receptor Type 2 (CR2/CD21) as a Receptor for IFN-α: A Potential Role in Systemic Lupus Erythematosus1

Rengasamy Asokan, V. Michael Holers, Jonathan P. Hannan, 2006, The Journal of Immunology.

Delineation of the complement receptor type 2-C3d complex by site-directed mutagenesis and molecular docking.

J. Thurman, J. Hannan, C. Shaw, 2010, Journal of molecular biology.

Isolating the Epstein-Barr Virus gp350/220 Binding Site on Complement Receptor Type 2 (CR2/CD21)*

V. Holers, J. Hannan, Xiaojiang S. Chen, 2007, Journal of Biological Chemistry.

Structure of Complement Receptor 2 in Complex with Its C3d Ligand

V. Michael Holers, J. Guthridge, V. Holers, 2001, Science.

Epitope Mapping Using the X-Ray Crystallographic Structure of Complement Receptor Type 2 (CR2)/CD21: Identification of a Highly Inhibitory Monoclonal Antibody That Directly Recognizes the CR2-C3d Interface1

John D Lambris, J. Lambris, S. Perkins, 2001, The Journal of Immunology.

Recognizes the CR 2-C 3 d of a Highly Inhibitory Monoclonal Antibody Receptor Type 2 ( CR 2 ) / CD 21 : Identification Crystallographic Structure of Complement Epitope Mapping Using the X-Ray

S. Perkins, J. Guthridge, J. James, 2001 .

Structure of the Epstein-Barr virus major envelope glycoprotein

Rengasamy Asokan, M. Klein, V. Holers, 2006, Nature Structural &Molecular Biology.

Molecular Basis of the Interaction between Complement Receptor Type 2 (CR2/CD21) and Epstein-Barr Virus Glycoprotein gp350

P. Barlow, V. Holers, J. Hannan, 2008, Journal of Virology.

Lower omega-3 fatty acids are associated with the presence of anti-cyclic citrullinated peptide autoantibodies in a population at risk for future rheumatoid arthritis: a nested case-control study.

P. Gregersen, J. Norris, M. Weisman, 2016, Rheumatology.

Mutational analysis of the complement receptor type 2 (CR2/CD21)-C3d interaction reveals a putative charged SCR1 binding site for C3d.

Rengasamy Asokan, J. Guthridge, V. Holers, 2005, Journal of molecular biology.

Structural studies in solution of the recombinant N-terminal pair of short consensus/complement repeat domains of complement receptor type 2 (CR2/CD21) and interactions with its ligand C3dg.

J Hinshelwood, John D Lambris, W. T. Moore, 2001, Biochemistry.